Dublin, February 15, 2021 (GLOBE NEWSWIRE) – Added to report “Organs-on-chips Market Analysis Report by Type, End User – Global Outlook to 2025 – Cumulative Impact of COVID-19” ResearchAndMarkets.com’s offering.
The Global Organs-on-chips Market is expected to grow from USD 20.53 Million in 2020 to USD 84.09 Million by the end of 2025
The report examines in depth the recent significant developments with the leading vendors and innovation profiles in the Global Organs-on-chips Market including AxoSim, Inc., BioIVT, CN Bio Innovations , Emulate, Inc., HemoShear Therapeutics, LLC, HREL Corporation, InSphero AG, Kirkstall Ltd., Mimetas, Nortis, Organovo, Inc., SynVivo, Inc., Tara Biosystems, and TissUse GmbH.
Cumulative impact of COVID-19:
COVID-19 is an unprecedented global public health crisis that has affected almost every industry, so for and, the long-term effects that are expected to affect the growth of the industry over time which is expected. The ongoing research enhances the research framework to ensure that COVID-19 underlying issues and potential pathways are covered.
The report delivers insight into COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, supply chain redirection, the dynamics of current market forces, and key government interventions. The updated study provides insights, analysis, estimates, and forecasts, considering the impact of COVID-19 on the market.
FPNV Location Matrix:
The FPNV Positioning Matrix evaluates and classifies vendors in the Organs-on-chips Market on the basis of Business Strategy (Business Growth, Business Coverage, Financial Capability, and Channel Support) and Product Satisfaction (Value for Money, Easy to Use, Product Features, and Customer Support) that help businesses make better decisions and understand the competitive landscape.
Competitive Strategic Window:
The Competitive Strategic Window analyzes a competitive landscape in terms of markets, applications and geography. The Competitive Strategic Window helps the vendor define alignment or appropriateness between their capabilities and the opportunities for future growth opportunities. Over a projected period, it explains the best or most favorable way for vendors to undertake continuous integration and construction strategies, geographic expansion, research & development, and delivery strategies. introduce new products to achieve business expansion and growth.
The report outlines the following recommendations:
1. Market Guide: Provides complete information about the market offered by the major players
2. Marketing Development: Provides in-depth information on emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information on new product launches, undeveloped geography, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides a comprehensive assessment of market segments, strategies, products, and manufacturing capabilities of key players
5. Product Development & Innovation: Provides insightful insights into future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the size and market outlook of the Global Organs-on-chips Market?
2. What are the inhibitory and inhibitory properties of COVID-19 that are shaping the Global Organs-on-chips Market in the foreseeable future?
3. What products / sections / applications / fields will you choose over the forecast period in the Global Organs-on-chips Market?
4. What is the competitive strategic window for opportunities in the Global Organs-on-chips Market?
5. What are the technology trends and regulatory frameworks in the Global Organs-on-chips Market?
6. What strategic approaches and trends are considered appropriate for entering the Global Organs-on-chips Market?
Key topics covered:
1. Introduction
1.1. Aims of the study
1.2. Seal & Market Coverage
1.3. Years considered for review
1.4. Money & Prices
1.5. Language
1.6. Restrictions
1.7. Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Execution of search
2.3. Search Results
3. Executive Minutes
3.1. Introduction
3.2. Market forecast
3.3. Application preview
3.4. Type Outlook
3.5. End-user preview
3.6. Geography Preview
3.7. Competitor preview
4. Market outlook
4.1. Introduction
4.2. Cumulative effect of COVID-19
5. Market views
5.1. Market dynamics
5.1.1. Drivers
5.1.1.1. More focus on developing alternatives for animal testing models
5.1.1.2. Significant increase in research funding and venture capital investments for organ-on-chips development
5.1.1.3. Technological advances and the launch of new products
5.1.1.4. Growing partnerships and collaborations between pharmaceutical companies and organ-on-chips manufacturers
5.1.1.5. Rising need for early detection of drug poisoning to reduce financial loss due to late drug failure
5.1.1.6. Growing initiatives to raise awareness of organ-on-chips technologies
5.1.2. Barriers
5.1.2.1. Issues related to the integration of organ-on-chips technologies into existing workflows
5.1.3. Opportunities
5.1.3.1. Growing focus on drug detection activities
5.1.3.2. Organ-on-chips implementation in oncology research
5.1.3.3. Development of multi-organ-on-a-chip models
5.1.4. Challenges
5.1.4.1. Complexity of organ-on-chips modules
5.1.4.2. Designed by skilled professionals
5.2. Five Force Analysis
6. Global Organs-on-chips market, by type
6.1. Introduction
6.2. Artery-on-a-chip
6.3. Brain-on-a-chip
6.4. Heart-on-a-chip
6.5. Kidney-on-a-chip
6.6. Lung-on-a-chip
6.7. Skin-on-a-chip
7. Global Organs-on-chips Market, By Demand
7.1. Introduction
7.2. Find drugs
7.3. Development of a Physiological Model
7.4. Toxicology research
8. Global Organs-on-chips Market, With End User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Cosmetics industry
8.4. Pharmaceutical & Biotechnology Companies
9. American Organan-on-chips Market
10. Asia-Pacific organ-on-chips market
11. Organan-on-chips Market Europe, Middle East & Africa
12. Competitive Landscape
12.1. FPNV Location Matrix
12.2. Market ranking analysis
12.3. Market segment analysis
12.4. Competitive SWOT Analysis
12.5. Competitive position
13. Company Usage Profiles
13.1. AxoSim, Inc.
13.2. BioIVT
13.3. CN Bio Innovations
13.4. Emulate, Inc.
13.5. HemoShear Therapeutics, LLC
13.6. Corporal HREL
13.7. InSphero AG
13.8. Kirkstall Limited.
13.9. Mimetas
13.10. Nortis
13.11. Organovo, Inc.
13.12. SynVivo, Inc.
13.13. Biosystems Tara
13.14. TissUse GmbH
For more information on this report, visit https://www.researchandmarkets.com/r/kmglap
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900